CGI-1746

• CAT Number: I005423
• CAS Number: 910232-84-7
• Molecular Formula: C₃₄H₃₇N₅O₄
• Molecular Weight: 579.69
• Purity: ≥95%
• Target: BTK
• Solubility: in DMSO > 10 mM
• Storage: Store at -20°C
• IUPAC Name: 4-tert-butyl-N-[2-methyl-3-[4-methyl-6-[4-(morpholine-4-carbonyl)anilino]-5-oxopyrazin-2-yl]phenyl]benzamide
• InChI: InChI=1S/C34H37N5O4/c1-22-27(7-6-8-28(22)37-31(40)23-9-13-25(14-10-23)34(2,3)4)29-21-38(5)33(42)30(36-29)35-26-15-11-24(12-16-26)32(41)39-17-19-43-20-18-39/h6-16,21H,17-20H2,1-5H3,(H,35,36)(H,37,40)
• InChIKey: JIFCFQDXHMUPGP-UHFFFAOYSA-N
• SMILES: CC1=C(C=CC=C1NC(=O)C2=CC=C(C=C2)C(C)(C)C)C3=CN(C(=O)C(=N3)NC4=CC=C(C=C4)C(=O)N5CCOCC5)C

CGI-1746 (Cat.No:I005423) is a potent and selective inhibitor of the tyrosine kinase enzyme known as Syk (spleen tyrosine kinase). Syk plays a critical role in immune cell signaling and activation. By inhibiting Syk, CGI-1746 has the potential to modulate immune responses and may have therapeutic applications in autoimmune diseases and certain types of cancer. 

Reference

[1]. Di Paolo, Julie A. et al. Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis. Nature Chemical Biology (2011), 7(1), 41-50